Steuten L, Goulart B, Meropol NJ, Pritchard D, Ramsey SD.
JCO Clinical Cancer Informatics, 2019 Jun.
Forse può anche interessarti
Neoadjuvant ipilimumab plus nivolumab in melanoma: 5...
Neoadjuvant Taxane Plus Trastuzumab and Pertuzumab...
Atezolizumab plus FOLFOX for Stage III Mismatch Repair...
Upfront Modified FOLFOXIRI Plus Panitumumab for...
Neoadjuvant CTLA-4/PD-(L)1 Blockade Versus Surgery +/...